SEC Form D private-offering filing
Canton Strategic Holdings, Inc.
A new SEC Form D private-offering notice from Red Bank, NJ, a $1,740,000 filer-stated offering target in Biotech. The source filing is one click away.
Nasdaq listed company, formerly Tharimmune, that combines clinical stage biotech research in inflammation and immunology with a digital asset treasury strategy built around the Canton Network.
Filed 2026-04-15Filed to raise $1,740,000First money in 2025-07-23Raised so far $1,740,000HQ (as filed) Red Bank, NJSector Biotech ✓Stage (inferred) SeedCall status Needs classification
Source linked the Form D on EDGAR↗Website verified cantonstrategic.com↗Named in the filing 10 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.